Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum
- 1 September 1999
- journal article
- Published by Microbiology Society in Microbiology
- Vol. 145 (9) , 2527-2532
- https://doi.org/10.1099/00221287-145-9-2527
Abstract
The DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum, which are species naturally resistant, moderately susceptible and susceptible to fluoroquinolones, respectively, were purified by affinity chromatography on novobiocin-Sepharose columns. The DNA gyrase inhibiting activities (IC50 values) of classical quinolones and fluoroquinolones were determined from the purified enzymes and were compared to the corresponding antibacterial activities (MICs). Regarding M. fortuitum bv. peregrinum, which is nearly as susceptible as Escherichia coli, the corresponding MIC and IC50 values of quinolones were significantly lower than those found for M. avium and M. smegmatis (e.g. for ofloxacin, MICs of 0·25 versus 32 and 1 μg ml−1, and IC50 values of 1 versus 8 and 6 μg ml−1, respectively). Such a result could be related to the presence of Ser-83 in the quinolone-resistance-determining region of the gyrase A subunit of M. fortuitum bv. peregrinum, as found in wild-type E. coli, instead of Ala-83 in M. avium and M. smegmatis, as found in fluoroquinolone-resistant E. coli mutants. The IC50 values of quinolones against the M. avium and M. smegmatis DNA gyrases were similar, while the corresponding MICs were 32-fold higher for M. avium when compared to M. smegmatis, suggesting that an additional mechanism, such as a low cell wall permeability or a drug efflux, could contribute to the low antibacterial potency of quinolones against M. avium.Keywords
This publication has 31 references indexed in Scilit:
- Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolonesAntimicrobial Agents and Chemotherapy, 1995
- Mycobacterial cell wall: Structure and role in natural resistance to antibioticsFEMS Microbiology Letters, 1994
- Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1994
- Amplification and nucleotide sequence of the quinolone resistance-determining region in thegyrAgene of mycobacteriaFEMS Microbiology Letters, 1994
- Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1992
- Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteinsAntimicrobial Agents and Chemotherapy, 1991
- Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolonesAntimicrobial Agents and Chemotherapy, 1989
- Mycobacteria and the new quinolonesAntimicrobial Agents and Chemotherapy, 1989
- Nalidixic acid resistance: A second genetic character involved in DNA gyrase activityProceedings of the National Academy of Sciences, 1977
- DNA gyrase: an enzyme that introduces superhelical turns into DNA.Proceedings of the National Academy of Sciences, 1976